BERWYN, PENNSYLVANIA and DUBLIN, IRELAND, 4 March 2025 - Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organisation, today announce a partnership to utilise the participant management and payments platform, Mural Link. ICON will ​utilise​ Mural Link’s innovative functionality related to clinical trial participant payments, tax management, travel and concierge support, site-participant communication tools, and novel reporting and analytics capabilities. “From our very first conversations with ICON, we were highly impressed by their commitment to patient care and innovation,” said Sam Whitaker, CEO of Mural Health. “This partnership represents a shared vision of removing barriers to trial participation​ and advancing participation financial neutrality​, while eliminating the need for site staff to manage highly manual, error-prone, and time-consuming administrative activities.”

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

BERWYN, Pa., May 15, 2024 /PRNewswire/ -- Mural Health , a patient-first clinical trial technology company, was named "Most Innovative Start-up" at the 2024 Citeline Awards. Hosted by Citeline (a leading provider of business intelligence in the pharmaceutical and medtech markets), this award recognizes a start-up pharma/biotech company that has developed creative and innovative approaches to the formidable challenges that clinical trials present to small organizations.Designed to meet the needs of modern-day clinical trial participants, Mural Health's proprietary product, Mural Link, is a patient-first participant management platform that simplifies the clinical trial experience for patients and caregivers and reduces the administrative burden for sites. Through one comprehensive platform, participants can:Get paid however they want (with no hidden fees, ever)Schedule their own travel with no out-of-pocket expensesCommunicate with sites and provide feedback easilyShare insights about their participant experience"This innovative approach helps trial participants and sponsors and should help expand access to trials, thereby increasing cohort diversity." - Citeline Awards judgesMural Link empowers sites and sponsors globally with exceptional engagement, streamlined operations, and better results to help transformative healthcare solutions get to market faster. It's the first product that gives the sponsor satisfaction and retention data in real-time across all sites in a study."Over the last 15 years, technology has evolved significantly, but the clinical research industry has not kept up. Participants deserve better," says Sam Whitaker, co-founder and CEO of Mural Health. "We need to meet patients and caregivers where they are, which is why we built Mural Link, a next-generation platform that is making it easier to participate in clinical trials for the benefit of all stakeholders